Oncomedicine 2017; 2:14-23. doi:10.7150/oncm.17097 This volume Cite

Review

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification

Konstantinos Grapatsas1, Vasilis Leivaditis1, Zoi Tsilogianni2, Eugene Haussmann1, Vasili Kaplunov1, Michael Dahm1, Paul Zarogoulidis3✉, Wolfgang Hohenforst-Schmidt4, Kosmas Tsakiridis5, Cristoforos Foroulis6, Dimitrios Paliouras7, Nikolaos Barbetakis7, Basili Kosan1

1. Department of Cardiothoracic and Vascular Surgery, Westpfalz Klinikum, Kaiserslautern, Germany.
2. 1st Department of Internal Medicine, 401 General Military Hospital, Athens, Greece.
3. Pulmonary Department-Oncology Unit, “G. Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
4. Medical Clinic I,''Fuerth'' Hospital, University of Erlangen, Fuerth, Germany.
5. Cardio-Thoracic Surgery Department, “Saint” Luke, Private Hospital, Panorama, Thessaloniki, Greece.
6. Cardio-Thoracic Surgery Department, “AHEPA” University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
7. Thoracic Surgery Department, Theagenio Cancer Hospital, Thessaloniki, Greece.

Citation:
Grapatsas K, Leivaditis V, Tsilogianni Z, Haussmann E, Kaplunov V, Dahm M, Zarogoulidis P, Hohenforst-Schmidt W, Tsakiridis K, Foroulis C, Paliouras D, Barbetakis N, Kosan B. Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification. Oncomedicine 2017; 2:14-23. doi:10.7150/oncm.17097. http://www.oncm.org/v02p0014.htm
Other styles

File import instruction

Abstract

Lung cancer is a primary health issue which preoccupies the health professional community worldwide. Lung cancer is one of the leading causes of death in both men and women in the developed countries. It is mainly divided into two types. The non small cell lung cancer (NSCLC) and the small cell lung cancer (SCLC). The NSCLC is the most common type and consists the 87% of lung cancer overall. The staging and the therapeutic approach of NSCLC is based on TNM classification system. Currently the 7th revision is being used for the appropriate classification of the cancer stadium. By the end of 2016 a new 8th TNM classification is awaited.

Keywords: Lung cancer, Smoking, Asbestos, Radon, lung cancer symptomatology, TNM.


Citation styles

APA
Grapatsas, K., Leivaditis, V., Tsilogianni, Z., Haussmann, E., Kaplunov, V., Dahm, M., Zarogoulidis, P., Hohenforst-Schmidt, W., Tsakiridis, K., Foroulis, C., Paliouras, D., Barbetakis, N., Kosan, B. (2017). Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification. Oncomedicine, 2, 14-23. https://doi.org/10.7150/oncm.17097.

ACS
Grapatsas, K.; Leivaditis, V.; Tsilogianni, Z.; Haussmann, E.; Kaplunov, V.; Dahm, M.; Zarogoulidis, P.; Hohenforst-Schmidt, W.; Tsakiridis, K.; Foroulis, C.; Paliouras, D.; Barbetakis, N.; Kosan, B. Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification. Oncomedicine 2017, 2, 14-23. DOI: 10.7150/oncm.17097.

NLM
Grapatsas K, Leivaditis V, Tsilogianni Z, Haussmann E, Kaplunov V, Dahm M, Zarogoulidis P, Hohenforst-Schmidt W, Tsakiridis K, Foroulis C, Paliouras D, Barbetakis N, Kosan B. Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification. Oncomedicine 2017; 2:14-23. doi:10.7150/oncm.17097. http://www.oncm.org/v02p0014.htm

CSE
Grapatsas K, Leivaditis V, Tsilogianni Z, Haussmann E, Kaplunov V, Dahm M, Zarogoulidis P, Hohenforst-Schmidt W, Tsakiridis K, Foroulis C, Paliouras D, Barbetakis N, Kosan B. 2017. Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification. Oncomedicine. 2:14-23.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.